Dow Chemical Company
Respiratory cancer risks among workers with glutaraldehyde exposure analyzed
Published in Pharma Investments, Ventures and Law Weekly, April 16th, 2006
According to a study from the United States, "Glutaraldehyde is a substance that represents a substantial portion of the human exposure to aldehydes in medicine and industry. Other aldehydes such as formaldehyde have been associated with increased cancer rates of the upper respiratory tract and leukemia."
"Our study is the only one, to our knowledge, to examine cancer rates among exposed glutaraldehyde workers," explained J.J. Collins and colleagues, Dow Chemical Company. "In an extended follow up using death certificates, we calculated standardized mortality...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma posts loss of $0.33 per share, reports APF530 phase III trial update - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences reports loss of $0.15 per share - Adventrx Pharmaceuticals, Inc.
Adventrx records loss of $0.03 per share - Akorn, Inc.
Akorn completes $19.4M private placement of common stock - AutoImmune, Inc.
AutoImmune reports loss of $0.01 per share - Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals reports 36% increase in sales - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
